KP-501

N/A

Report date: 2022/10/19 09:40:51

Base Information

Drug NameKP-501
Drug Alias NameKP-501
ClassificationBiologics
Mechanisms of ActionComplement system proteins inhibitors
TargetsComplement system proteins
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKira Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesKira Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A